Law360, New York (November 17, 2008, 12:00 AM ET) -- Teva Pharmaceutical Industries Ltd. has agreed to drop two patents from an infringement suit against rivals Zydus Pharmaceuticals Inc. and Cadila Healthcare Ltd. over a patented process for making the key ingredient in the congestive heart treatment Coreg, but Zydus' invalidity and antitrust-related counterclaims for one of those patents remain in play.
U.S. District Judge Garrett E. Brown of the U.S. District Court for the District of New Jersey on Thursday signed off on an order dismissing with prejudice Teva's claims under U.S. Patent Numbers 7,056,942...
Teva, Zydus Drop Some Claims In Coreg Patent Suit
To view the full article, take a free trial now.
